Skip to main content
Erschienen in: Annals of Surgical Oncology 4/2010

01.04.2010 | Colorectal Cancer

Is Total Mesorectal Excision Always Necessary for T1–T2 Lower Rectal Cancer?

verfasst von: Hirotoshi Kobayashi, MD, Hidetaka Mochizuki, MD, Tomoyuki Kato, MD, Takeo Mori, MD, Shingo Kameoka, MD, Kazuo Shirouzu, MD, Yukio Saito, MD, Masahiko Watanabe, MD, Takayuki Morita, MD, Jin-ichi Hida, MD, Masashi Ueno, MD, Masato Ono, MD, Masamichi Yasuno, MD, Kenichi Sugihara, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The goal of this multicenter study was to clarify the determinants of local excision for patients with T1–T2 lower rectal cancer.

Methods

Data from 567 consecutive patients who underwent radical resection for T1–T2 lower rectal cancer at 12 institutions between 1991 and 1998 were reviewed. Rates of lymph node metastasis were investigated using a tree analysis, which was hierarchized using independent risk factors for nodal involvement.

Results

The independent risk factors for lymph node metastasis were female gender, depth of tumor invasion, histology other than well-differentiated adenocarcinoma, and lymphatic invasion. According to the first three parameters that can be obtained preoperatively, only 0.99% of the patients without risk factors had lymph node metastasis. On the other hand, even if the lower rectal cancer was at stage T1, women with histological types other than well-differentiated adenocarcinoma had an approximately 30% probability of having lymph node metastasis. Lymphatic invasion was most useful to predict nodal involvement among patients with T2 lower rectal cancer. The rates of lymph node metastasis in T2 patients with and without lymphatic invasion were 32.9% and 9.1%, respectively.

Conclusions

Gender is one of the most important predictors for lymph node metastasis in patients with early distal rectal cancer. Three parameters, including depth of tumor invasion, histology, and gender, are useful determinants for local excision. Additional studies are required to establish the minimum optimal treatment for T2 lower rectal cancer.
Literatur
1.
Zurück zum Zitat Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–9.CrossRefPubMed Heald RJ, Moran BJ, Ryall RD, et al. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133(8):894–9.CrossRefPubMed
2.
Zurück zum Zitat Kobayashi H, Mochizuki H, Sugihara K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67–75.CrossRefPubMed Kobayashi H, Mochizuki H, Sugihara K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67–75.CrossRefPubMed
3.
Zurück zum Zitat Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242(4):472–7; discussion 477–9.PubMed Bentrem DJ, Okabe S, Wong WD, et al. T1 adenocarcinoma of the rectum: transanal excision or radical surgery? Ann Surg. 2005;242(4):472–7; discussion 477–9.PubMed
4.
Zurück zum Zitat Endreseth BH, Myrvold HE, Romundstad P, et al (2005). Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 48(7): 1380–8.CrossRefPubMed Endreseth BH, Myrvold HE, Romundstad P, et al (2005). Transanal excision vs. major surgery for T1 rectal cancer. Dis Colon Rectum. 48(7): 1380–8.CrossRefPubMed
5.
Zurück zum Zitat Garcia-Aguilar J, Mellgren A, Sirivongs P, et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg. 2000;231(3):345–51.CrossRefPubMed Garcia-Aguilar J, Mellgren A, Sirivongs P, et al. Local excision of rectal cancer without adjuvant therapy: a word of caution. Ann Surg. 2000;231(3):345–51.CrossRefPubMed
6.
Zurück zum Zitat Hager T, Gall FP, Hermanek P. Local excision of cancer of the rectum. Dis Colon Rectum. 1983;26(3):149–51.CrossRefPubMed Hager T, Gall FP, Hermanek P. Local excision of cancer of the rectum. Dis Colon Rectum. 1983;26(3):149–51.CrossRefPubMed
7.
Zurück zum Zitat You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245(5):726–33.CrossRefPubMed You YN, Baxter NN, Stewart A, Nelson H. Is the increasing rate of local excision for stage I rectal cancer in the United States justified? A nationwide cohort study from the National Cancer Database. Ann Surg. 2007;245(5):726–33.CrossRefPubMed
8.
Zurück zum Zitat Martling AL, Holm T, Rutqvist LE, et al (2000). Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 356(9224): 93–6.CrossRefPubMed Martling AL, Holm T, Rutqvist LE, et al (2000). Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet. 356(9224): 93–6.CrossRefPubMed
9.
Zurück zum Zitat Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer. 1992;69(2):322–6.CrossRefPubMed Brodsky JT, Richard GK, Cohen AM, Minsky BD. Variables correlated with the risk of lymph node metastasis in early rectal cancer. Cancer. 1992;69(2):322–6.CrossRefPubMed
10.
Zurück zum Zitat Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg. 1982;144(3):350–4.CrossRefPubMed Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg. 1982;144(3):350–4.CrossRefPubMed
11.
Zurück zum Zitat Hughes TG, Jenevein EP, Poulos E (1983). Intramural spread of colon carcinoma. A pathologic study. Am J Surg. 146(6): 697–9.CrossRefPubMed Hughes TG, Jenevein EP, Poulos E (1983). Intramural spread of colon carcinoma. A pathologic study. Am J Surg. 146(6): 697–9.CrossRefPubMed
12.
Zurück zum Zitat Witte D, Chirala M, Younes A, et al. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol. 2001;32(9):940–4.CrossRefPubMed Witte D, Chirala M, Younes A, et al. Estrogen receptor beta is expressed in human colorectal adenocarcinoma. Hum Pathol. 2001;32(9):940–4.CrossRefPubMed
13.
Zurück zum Zitat Kuruppu D, Christophi C, Bertram JF, O’Brien PE. Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol. 1998;13(5):521–7.CrossRefPubMed Kuruppu D, Christophi C, Bertram JF, O’Brien PE. Tamoxifen inhibits colorectal cancer metastases in the liver: a study in a murine model. J Gastroenterol Hepatol. 1998;13(5):521–7.CrossRefPubMed
14.
Zurück zum Zitat Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg. 1999;230(1):49–54.CrossRefPubMed Chakravarti A, Compton CC, Shellito PC, et al. Long-term follow-up of patients with rectal cancer managed by local excision with and without adjuvant irradiation. Ann Surg. 1999;230(1):49–54.CrossRefPubMed
15.
Zurück zum Zitat Koscinski T, Malinger S, Drews M. Local excision of rectal carcinoma not-exceeding the muscularis layer. Colorectal Dis. 2003;5(2):159–63.CrossRefPubMed Koscinski T, Malinger S, Drews M. Local excision of rectal carcinoma not-exceeding the muscularis layer. Colorectal Dis. 2003;5(2):159–63.CrossRefPubMed
16.
Zurück zum Zitat Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43(8):1064–71; discussion 1071–4.CrossRefPubMed Mellgren A, Sirivongs P, Rothenberger DA, et al. Is local excision adequate therapy for early rectal cancer? Dis Colon Rectum. 2000;43(8):1064–71; discussion 1071–4.CrossRefPubMed
17.
Zurück zum Zitat Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum. 2004;47(11):1773–9.CrossRefPubMed Nascimbeni R, Nivatvongs S, Larson DR, Burgart LJ. Long-term survival after local excision for T1 carcinoma of the rectum. Dis Colon Rectum. 2004;47(11):1773–9.CrossRefPubMed
18.
Zurück zum Zitat Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236(4):522–29; discussion 529–30.CrossRefPubMed Paty PB, Nash GM, Baron P, et al. Long-term results of local excision for rectal cancer. Ann Surg. 2002;236(4):522–29; discussion 529–30.CrossRefPubMed
19.
Zurück zum Zitat Benson R, Wong CS, Cummings BJ, et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys. 2001;50(5):1309–16.PubMed Benson R, Wong CS, Cummings BJ, et al. Local excision and postoperative radiotherapy for distal rectal cancer. Int J Radiat Oncol Biol Phys. 2001;50(5):1309–16.PubMed
20.
Zurück zum Zitat Bouvet M, Milas M, Giacco GG, et al. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol. 1999;6(1):26–32.CrossRefPubMed Bouvet M, Milas M, Giacco GG, et al. Predictors of recurrence after local excision and postoperative chemoradiation therapy of adenocarcinoma of the rectum. Ann Surg Oncol. 1999;6(1):26–32.CrossRefPubMed
21.
Zurück zum Zitat Mendenhall WM, Morris CG, Rout WR, et al. Local excision and postoperative radiation therapy for rectal adenocarcinoma. Int J Cancer. 2001;96(Suppl):89–96.CrossRefPubMed Mendenhall WM, Morris CG, Rout WR, et al. Local excision and postoperative radiation therapy for rectal adenocarcinoma. Int J Cancer. 2001;96(Suppl):89–96.CrossRefPubMed
22.
Zurück zum Zitat Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys. 2000;46(2):313–22.CrossRefPubMed Russell AH, Harris J, Rosenberg PJ, et al. Anal sphincter conservation for patients with adenocarcinoma of the distal rectum: long-term results of radiation therapy oncology group protocol 89-02. Int J Radiat Oncol Biol Phys. 2000;46(2):313–22.CrossRefPubMed
23.
Zurück zum Zitat Steele GD, Jr., Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol. 1999;6(5):433–41.CrossRefPubMed Steele GD, Jr., Herndon JE, Bleday R, et al. Sphincter-sparing treatment for distal rectal adenocarcinoma. Ann Surg Oncol. 1999;6(5):433–41.CrossRefPubMed
24.
Zurück zum Zitat Ota DM, Nelson H. Local excision of rectal cancer revisited: ACOSOG protocol Z6041. Ann Surg Oncol. 2007;14(2):271.CrossRefPubMed Ota DM, Nelson H. Local excision of rectal cancer revisited: ACOSOG protocol Z6041. Ann Surg Oncol. 2007;14(2):271.CrossRefPubMed
Metadaten
Titel
Is Total Mesorectal Excision Always Necessary for T1–T2 Lower Rectal Cancer?
verfasst von
Hirotoshi Kobayashi, MD
Hidetaka Mochizuki, MD
Tomoyuki Kato, MD
Takeo Mori, MD
Shingo Kameoka, MD
Kazuo Shirouzu, MD
Yukio Saito, MD
Masahiko Watanabe, MD
Takayuki Morita, MD
Jin-ichi Hida, MD
Masashi Ueno, MD
Masato Ono, MD
Masamichi Yasuno, MD
Kenichi Sugihara, MD
Publikationsdatum
01.04.2010
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 4/2010
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-009-0849-y

Weitere Artikel der Ausgabe 4/2010

Annals of Surgical Oncology 4/2010 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.